Skip to search formSkip to main contentSkip to account menu

Kremezin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Abstract AST-120 (KREMEZIN®) consists of oral, spherical carbon particles that adsorb uremic toxins and their precursors within… 
2017
2017
Background We investigated the long-term effect of AST-120, which has been proposed as a therapeutic option against renal disease… 
Review
2012
Review
2012
Although protein-bound uremic retention solutes are recognized as 1 of the 3 main categories of uremic retention solutes, they… 
Highly Cited
2011
Highly Cited
2011
The recent interest in the role of the intestine in the cardiovascular stability of uremic patients, specifically on dialysis… 
Review
2010
Review
2010
Part of the uremic retention solutes are generated in the intestine, but this option is rarely discussed in the literature. In… 
2007
2007
OBJECTIVES Indoxyl sulfate shows nephrotoxicity and is a stimulating factor for progression of chronic kidney disease (CKD). This… 
Highly Cited
2006
Highly Cited
2006
BACKGROUND AST-120 (Kremezin; Kureha Chemical Industry Co Ltd, Tokyo, Japan) is an orally administered adsorbent showing… 
Highly Cited
2004
Highly Cited
2004
Background/Aim: Intima media thickness (IMT) and stiffness of the carotid arteries is related to coronary artery disease, and… 
2002
2002
The aim of the present study was to determine if treatment with an oral adsorbent (AST-120, Kremezin®) might decrease the urinary…